E2f As a Target for Treatment of Hormone Refractory Prostate Cancer

The instant invention provides amino acid sequences competing with E2F for DNA binding. Methods of using said amino acid sequences for treatment of hormone-refractory prostate cancer are also provided.

Patents:
WO 2,010,120,931

Inventor(s): BERTINO JOSEPH R [US]; BANERJEE DEBABRATA [US]; MINKO TAMARA [US]; GARBUZENKO OLGA B [US]; XIE XIAOQI [US]; KERRIGAN JOHN EDWARD

Type of Offer: Licensing



« More Biotech Patents

---